Farag, Mena;
Murphy, Michael J;
Hobbs, Nicola Z;
Leocadi, Michela;
Fayer, Kate;
Thackeray, Olivia;
Gobom, Johan;
... Scahill, Rachael I; + view all
(2025)
Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease.
Movement Disorders
10.1002/mds.70062.
(In press).
Preview |
Text
Movement Disorders - 2025 - Farag - Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical.pdf - Published Version Download (1MB) | Preview |
Abstract
Background: Huntington's disease (HD) is characterized by early, selective, progressive vulnerability of striatal medium spiny neurons (MSNs). Proenkephalin (PENK), a precursor of opioid peptides abundantly expressed in MSNs, is a promising biomarker of striatal integrity, but region‐specific associations and its potential for early‐stage discrimination have not been characterized. Objectives: We investigated cross‐sectional and longitudinal associations between baseline cerebrospinal fluid (CSF) PENK concentration and regional brain atrophy, compared identified patterns with CSF neurofilament light (NfL), and evaluated PENK and NfL for discriminating between HD Integrated Staging System (HD‐ISS) stage 0 versus 1 in a far‐from‐onset HD gene‐expanded (HDGE) cohort. Methods: Whole‐brain voxel‐based morphometry was performed in 149 participants (72 HDGE, 77 controls) cross‐sectionally and 88 participants (54 HDGE, 34 controls) longitudinally over a mean interval of 4.8 years. Voxel‐wise linear regression tested associations between baseline biofluid biomarkers and gray/white matter volume, adjusting for age, sex and CAG‐Age Product score, with false discovery rate correction. Logistic regression and receiver operating characteristic analyses assessed stage discrimination. Results: Lower baseline CSF PENK predicted longitudinal gray and white matter loss, predominantly in the striatum bilaterally. Higher baseline CSF NfL predicted widespread longitudinal white matter loss. For stage discrimination, PENK (area under curve [AUC], 0.706; P = 0.0002) outperformed NfL (AUC, 0.661; P = 0.1596) with minimal gain from combining both (AUC, 0.714; joint P = 0.0007). Conclusions: Lower baseline CSF PENK concentration predicted longitudinal striatal atrophy and CSF PENK outperformed CSF NfL in distinguishing HD‐ISS stages 0 and 1, supporting its role as a striatum‐specific biomarker with potential to enrich early‐stage HD trial cohorts. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
| Type: | Article |
|---|---|
| Title: | Cerebrospinal Fluid Proenkephalin Predicts Striatal Atrophy Decades before Clinical Motor Diagnosis in Huntington's Disease |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1002/mds.70062 |
| Publisher version: | https://doi.org/10.1002/mds.70062 |
| Language: | English |
| Additional information: | © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10214552 |
Archive Staff Only
 |
View Item |
